Effects of the sodium‐glucose cotransporter 2 inhibitor empagliflozin on vascular function in patients with chronic heart failure

Abstract Aims Impairment of vascular function contributes to the progression of chronic heart failure (HF) by increasing the afterload. Treatment with selective sodium‐glucose cotransporter 2 (SGLT2) inhibitors improves the prognosis of HF, but the precise mechanisms remain unclear. The aim of this...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Julie Kolwelter, Agnes Bosch, Susanne Jung, Lena Stabel, Dennis Kannenkeril, Christian Ott, Peter Bramlage, Mario Schiffer, Stephan Achenbach, Roland E. Schmieder
格式: Artigo
語言:Inglês
出版: Wiley 2021-12-01
叢編:ESC Heart Failure
主題:
Chronic heart failure
Empagliflozin
SGLT2 inhibitor
Vascular function
Central haemodynamics
Blood pressure
在線閱讀:https://doi.org/10.1002/ehf2.13622
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍